Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Pacira BioSciences, Inc. (PCRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/04/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 509 shares
@ $34.875, valued at
$17.8k
|
|
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,950 shares
@ $0
Granted 27,500 options to buy
@ $38.74, valued at
$1.1M
|
|
| 06/16/2023 |
4
| Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,950 shares
@ $0
Sold 6,467 shares
@ $37.03, valued at
$239.5k
Granted 27,500 options to buy
@ $38.74, valued at
$1.1M
|
|
| 06/16/2023 |
4
| STACK DAVID M (CEO and Chairman) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 245,400 options to buy
@ $38.74, valued at
$9.5M
|
|
| 06/16/2023 |
4
| Riker Lauren Bullaro (Senior Vice President, Finance) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Sold 586 shares
@ $37.47, valued at
$22k
Sold 5,773 shares
@ $38.52, valued at
$222.4k
Sold 7 shares
@ $39.01, valued at
$273.1
Granted 25,000 options to buy
@ $38.74, valued at
$968.5k
|
|
| 06/16/2023 |
4
| Reinhart Charles A. III (CFO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 22,500 options to buy
@ $38.74, valued at
$871.7k
|
|
| 06/16/2023 |
4
| PACE GARY W (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| GAUGLER DARYL (COO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 25,000 options to buy
@ $38.74, valued at
$968.5k
|
|
| 06/16/2023 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| CHRISTIE CHRISTOPHER (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/16/2023 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/12/2023 |
4
| Kronenfeld Mark A. (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 15,000 shares
@ $37.04, valued at
$555.6k
Exercised 15,000 options to buy
@ $29.9, valued at
$448.5k
|
|
| 06/07/2023 |
4
| WINSTON ROY (Chief Medical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,779 shares
@ $38.991, valued at
$69.4k
Sold 1,857 shares
@ $37.865, valued at
$70.3k
|
|
| 06/07/2023 |
4
| Williams Kristen Marie (Chief Administrative Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,301 shares
@ $38.991, valued at
$50.7k
Sold 1,357 shares
@ $37.865, valued at
$51.4k
|
|
| 06/07/2023 |
4
| STACK DAVID M (CEO and Chairman) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 5,058 shares
@ $38.991, valued at
$197.2k
Sold 5,326 shares
@ $37.865, valued at
$201.7k
|
|
| 06/07/2023 |
4
| SLONIN JONATHAN (Chief Clinical Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 471 shares
@ $38.991, valued at
$18.4k
Sold 490 shares
@ $37.865, valued at
$18.6k
|
|
| 06/07/2023 |
4
| Riker Lauren Bullaro (Senior Vice President, Finance) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 591 shares
@ $38.991, valued at
$23k
Sold 616 shares
@ $37.865, valued at
$23.3k
|
|
| 06/07/2023 |
4
| Reinhart Charles A. III (CFO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,236 shares
@ $38.991, valued at
$48.2k
Sold 1,371 shares
@ $37.865, valued at
$51.9k
|
|
| 06/07/2023 |
4
| REINHARDT MAX (President, Rest of World) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,054 shares
@ $38.991, valued at
$41.1k
Sold 1,099 shares
@ $37.865, valued at
$41.6k
|
|
| 06/07/2023 |
4
| MOLLOY ANTHONY (Chief Lgl & Compliance Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 2,267 shares
@ $38.277, valued at
$86.8k
Sold 4,521 shares
@ $38.55, valued at
$174.3k
|
|
| 06/07/2023 |
4
| McLoughlin Dennis (Chief Customer Officer) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,014 shares
@ $38.991, valued at
$39.5k
Sold 1,057 shares
@ $37.865, valued at
$40k
|
|
| 06/07/2023 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 580 shares
@ $38.339, valued at
$22.2k
|
|
| 06/07/2023 |
4
| GAUGLER DARYL (COO) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 1,000 shares
@ $38.74, valued at
$38.7k
Sold 1,005 shares
@ $38.991, valued at
$39.2k
Sold 1,047 shares
@ $37.865, valued at
$39.6k
|
|
|
|
|